pac · NY

CARE IN ACTION

An outside-spending committee: $4.5M in independent expenditures ($4.3M supporting, $142K opposing candidates) - reported to the FEC, and by law not contributions to any campaign.

$4.5M
Independent expenditures
$4.3M
Supporting
$142K
Opposing

The verdict

CARE IN ACTION is an outside-spending committee: it made $4.5M in independent expenditures across 12 candidates, mostly supporting ($4.3M).

$4.3M
spent supporting candidates
$142K
spent opposing candidates

Candidates targeted

12

races with outside spending

Supporting

$4.3M

independent expenditures for

Opposing

$142K

independent expenditures against

Independent expenditures by CARE IN ACTION

Money this committee spent independently to support or oppose candidates, reported to the FEC, and by law not contributions to any campaign and not coordinated with it.

$4.5M
Total outside spending
$4.3M
Supporting
$142K
Opposing
Candidate Supporting Opposing
Kamala Harris $3.7M $2K
Raquel Teran $261K -
Ruben Gallego $202K -
Donald J. Trump - $140K
Jacky Rosen $116K -
Cheri Beasley $33K -
Tammy Baldwin $10K -
Robert P. Jr. Casey $10K -
Joseph R Jr Biden $4K -
Krystle Matthews $3K -
Jennifer Mcclellan $2K -
Nida Allam $645 -
Lobbying share of total influence 100.0%

Higher share = lobbying-heavy strategy vs. contributions or contracts

What CARE IN ACTION's influence footprint shows

CARE IN ACTION is an outside-spending committee: rather than contributing to candidates' committees, it reported $4.5M in independent expenditures to the Federal Election Commission - $4.3M advocating for candidates and $142K opposing them, across 12 races. By law these expenditures are made independently of, and uncoordinated with, any campaign, and they are not subject to contribution limits, which is how a single committee can deploy this scale of money. They are reported here separately from contributions because they are a fundamentally different mechanism of political influence.

Its lobbying profile spans 2 reporting years across 8 distinct LDA issue areas, with emphasis on Budget/Appropriations, Health Issues, Labor Issues/Antitrust/Workplace.

Lobbying by year

Year Amount
2024 $560K
2023 $370K

Frequently asked questions

How much political influence does CARE IN ACTION have?

CARE IN ACTION has a combined political influence footprint of $930K, made up of $930K in lobbying expenditures. This data comes from FEC filings, Senate LDA disclosures, and USAspending.gov records for 2023-2024.

What issues does CARE IN ACTION lobby on?

CARE IN ACTION spent $930K on federal lobbying. Key issue areas include Budget/Appropriations, Health Issues, Labor Issues/Antitrust/Workplace. Lobbying disclosures are filed under the Senate Lobbying Disclosure Act (LDA) and are public record.

Where does the data about CARE IN ACTION come from?

PlainInfluence aggregates data from three federal sources: the Federal Election Commission (FEC) for campaign contributions, the Senate Office of Public Records for lobbying disclosures under the Lobbying Disclosure Act, and USAspending.gov for federal contract awards. Data covers the 2023-2024 reporting period.

What is "total influence" and how is it calculated?

Total influence is the sum of an organization's campaign contributions, lobbying spending, and federal contract values. It provides a single metric for comparing the overall political and economic footprint of organizations in the federal arena. Each component is independently sourced from official government filings.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainInfluence Editorial.

Every figure on PlainInfluence is rendered directly from official FEC, Senate LDA and USAspending records, no number is typed in by an editor. Contribution, lobbying, and contract totals are aggregated directly from FEC, Senate LDA, and USAspending bulk data, no figure is hand-entered. Disclosed contributions, lobbying, and contracts are lawful, regulated activities, appearing on this page is not an allegation of wrongdoing. See our editorial standards & corrections policy, the methodology behind these numbers, our disclaimer, or report a data error. Data current as of 2023-2024.